HK1100945A1 - Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents - Google Patents

Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Info

Publication number
HK1100945A1
HK1100945A1 HK07108953.1A HK07108953A HK1100945A1 HK 1100945 A1 HK1100945 A1 HK 1100945A1 HK 07108953 A HK07108953 A HK 07108953A HK 1100945 A1 HK1100945 A1 HK 1100945A1
Authority
HK
Hong Kong
Prior art keywords
analogs
salts
tumor agents
isophosphoramide mustard
isophosphoramide
Prior art date
Application number
HK07108953.1A
Other languages
English (en)
Inventor
Lee Morgan
Original Assignee
Dekk Tec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dekk Tec Inc filed Critical Dekk Tec Inc
Publication of HK1100945A1 publication Critical patent/HK1100945A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/222Amides of phosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/664Amides of phosphorus acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK07108953.1A 2004-10-25 2007-08-16 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents HK1100945A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62208704P 2004-10-25 2004-10-25
US67270705P 2005-04-18 2005-04-18
PCT/US2005/038523 WO2006047575A2 (en) 2004-10-25 2005-10-25 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Publications (1)

Publication Number Publication Date
HK1100945A1 true HK1100945A1 (en) 2007-11-16

Family

ID=35788704

Family Applications (2)

Application Number Title Priority Date Filing Date
HK07108953.1A HK1100945A1 (en) 2004-10-25 2007-08-16 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
HK15110402.4A HK1209752A1 (en) 2004-10-25 2015-10-22 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15110402.4A HK1209752A1 (en) 2004-10-25 2015-10-22 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Country Status (17)

Country Link
US (4) US7678778B2 (ja)
EP (3) EP2336139A3 (ja)
JP (1) JP5336082B2 (ja)
KR (2) KR20130041384A (ja)
CN (3) CN101087800B (ja)
AU (1) AU2005299385B2 (ja)
CA (1) CA2585125C (ja)
DK (2) DK1805192T3 (ja)
ES (2) ES2397165T3 (ja)
HK (2) HK1100945A1 (ja)
IL (3) IL182752A (ja)
NO (1) NO20072478L (ja)
NZ (2) NZ589418A (ja)
PL (1) PL1805192T3 (ja)
PT (1) PT1805192E (ja)
SI (1) SI1805192T1 (ja)
WO (1) WO2006047575A2 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101087800B (zh) 2004-10-25 2015-01-07 德克技术公司 作为抗肿瘤剂的异磷酰胺氮芥及其类似物的盐
US7964583B2 (en) 2006-02-17 2011-06-21 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
JP5659010B2 (ja) * 2007-04-06 2015-01-28 ジオファーム オンコロジー, インコーポレイテッドZiopharm Oncology,Inc. イソホスホルアミドマスタードの塩およびそれらの類似体
EP2318013A4 (en) * 2008-07-31 2013-07-24 Ziopharm Oncology Inc SYNTHESIS AND FORMULATION OF ISOPHOSPHORAMIDE MUSTARD SALTS AND THEIR ANALOGUES
JP5779106B2 (ja) * 2009-02-24 2015-09-16 デック−テック, インコーポレイテッド 抗腫瘍剤としての4−ヒドロペルオキシイホスファミドの錯体
CN102659841B (zh) * 2012-04-24 2015-03-25 石家庄学院 多元酚磷酰胺衍生物及其制备方法与应用
CA2899206C (en) 2013-01-24 2019-07-09 Transderm, Inc. Compositions for transdermal delivery of mtor inhibitors
WO2017044453A1 (en) * 2015-09-10 2017-03-16 Becton, Dickinson And Company Cyclophosphamide analogs for use as immunogens and assay conjugates for an immunoassay of cyclophosphamide and ifosfamide
CN110520097B (zh) 2017-01-06 2023-10-27 帕尔维拉治疗股份有限公司 Mtor抑制剂的无水组合物及其使用方法
US11199529B2 (en) 2017-09-21 2021-12-14 Becton, Dickinson And Company Hazardous contaminant collection kit and rapid testing
JP2021530463A (ja) 2018-07-02 2021-11-11 パルヴェラ セラピューティクス、インク. mTOR阻害剤の無水組成物および使用方法
CN112888698A (zh) * 2018-09-25 2021-06-01 美国政府(由卫生和人类服务部的部长所代表) 2’-卤代-4’-硫代-2’-脱氧-5-氮杂胞苷类似物及其使用方法
CN212748381U (zh) 2019-01-28 2021-03-19 贝克顿·迪金森公司 一种有害污染物检测系统和一种有害污染物收集装置
CN111973583A (zh) * 2020-07-29 2020-11-24 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 芹菜素在制备促进缺血超长随意皮瓣存活药物的作用
CN111943979B (zh) 2020-10-19 2020-12-22 南京卓康医药科技有限公司 一种异环磷酰胺中间体及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU427945A1 (ru) 1972-07-24 1974-05-15 Институт элементоорганических соединений СПОСОБ ПОЛУЧЕНИЯа ПОЛИФТОРАЛКИЛЗАМЕЩЕННЫХБЕНЗИЛДИХЛОРФОСФАТОВ
JPS5159886A (ja) 1974-11-20 1976-05-25 Shionogi Seiyaku Kk
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
PL264222A1 (en) * 1986-02-22 1988-04-14 Method of obtaining novel heterocyclic compounds with 2-(2-/n,n-bis-(2-chloroethyl)-diamido-phosphoryloxy/ethyl)group
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
US4841085A (en) * 1986-06-30 1989-06-20 Board Of Regents, University Of Texas System Aldophosphamides
ATE181551T1 (de) 1992-04-17 1999-07-15 Abbott Lab Taxol-derivate
US5468499A (en) * 1993-11-15 1995-11-21 Ohio State University Liposomes containing the salt of phosphoramide mustard and related compounds
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
CA2373634C (en) * 1999-05-24 2010-04-13 Southern Research Institute Isophosphoramide mustard analogs and use thereof
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
CA2406160A1 (en) 2000-04-13 2001-10-25 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation
DE10064312C2 (de) * 2000-12-22 2003-05-22 Degussa Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung
DE60330407D1 (de) 2002-08-23 2010-01-14 Sloan Kettering Inst Cancer Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung
CN101087800B (zh) * 2004-10-25 2015-01-07 德克技术公司 作为抗肿瘤剂的异磷酰胺氮芥及其类似物的盐
JP5659010B2 (ja) * 2007-04-06 2015-01-28 ジオファーム オンコロジー, インコーポレイテッドZiopharm Oncology,Inc. イソホスホルアミドマスタードの塩およびそれらの類似体
EP2318013A4 (en) * 2008-07-31 2013-07-24 Ziopharm Oncology Inc SYNTHESIS AND FORMULATION OF ISOPHOSPHORAMIDE MUSTARD SALTS AND THEIR ANALOGUES

Also Published As

Publication number Publication date
SI1805192T1 (sl) 2013-02-28
DK1805192T3 (da) 2013-02-04
KR101292026B1 (ko) 2013-08-01
EP2336140A2 (en) 2011-06-22
IL211936A0 (en) 2011-05-31
IL211935A0 (en) 2011-05-31
PL1805192T3 (pl) 2013-03-29
CN104558023A (zh) 2015-04-29
CN103172662A (zh) 2013-06-26
US9346836B2 (en) 2016-05-24
CN101087800A (zh) 2007-12-12
WO2006047575A2 (en) 2006-05-04
EP1805192B1 (en) 2012-10-17
EP2336140B1 (en) 2016-01-27
US8232262B2 (en) 2012-07-31
EP2336139A3 (en) 2012-01-04
KR20070121632A (ko) 2007-12-27
EP2336139A2 (en) 2011-06-22
AU2005299385A1 (en) 2006-05-04
ES2565929T3 (es) 2016-04-07
KR20130041384A (ko) 2013-04-24
US8795659B2 (en) 2014-08-05
JP2008517949A (ja) 2008-05-29
US7678778B2 (en) 2010-03-16
NO20072478L (no) 2007-06-25
CN101087800B (zh) 2015-01-07
US20080267945A1 (en) 2008-10-30
CA2585125A1 (en) 2006-05-04
IL182752A0 (en) 2007-07-24
NZ555323A (en) 2010-12-24
IL182752A (en) 2012-09-24
PT1805192E (pt) 2013-01-23
IL211936A (en) 2012-12-31
NZ589418A (en) 2012-03-30
CA2585125C (en) 2014-04-22
EP2336140A3 (en) 2012-01-11
US20130149296A1 (en) 2013-06-13
JP5336082B2 (ja) 2013-11-06
US20060089333A1 (en) 2006-04-27
ES2397165T3 (es) 2013-03-05
HK1209752A1 (en) 2016-04-08
WO2006047575A3 (en) 2006-08-10
US20150152125A1 (en) 2015-06-04
AU2005299385B2 (en) 2011-06-16
DK2336140T3 (en) 2016-03-21
EP1805192A2 (en) 2007-07-11

Similar Documents

Publication Publication Date Title
HK1209752A1 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
EP1788874A4 (en) 5-AZACYTIDINE SALTS
AP2006003768A0 (en) TetraazabenzoÄeÜazulene derivatives and analogs tehereof
ZA200802501B (en) Indenoisoquinolinone analogs and methods of use thereof
EP1968937A4 (en) DIAZAPURIN ANALOGUES OF 1'-AZA-L-NUCLEOSIDES
PL1802579T3 (pl) Pochodne 3-aryloaminopirydynowe
EP1773871A4 (en) COMPOUNDS ASSOCIATED WITH TISSUE DIFFERENTIATION FACTOR AND THEIR ANALOGUES
EP1874731A4 (en) CHINOBENZOXAZINANALOGA AND METHOD FOR THE APPLICATION
IL176932A0 (en) Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
EP1778618A4 (en) SYNTHESIS OF TRIETHYLENETETRAMINES
IL185747A0 (en) Use of supplemental assignments
ZA200700357B (en) Tetrapetide analogs
EP1771453A4 (en) DIPEPTIDE ANALOGUE AS HEPATITIS C HEMMER
EP1901763A4 (en) THYROTROPIN RELEASE HORMONE ANALOGUES AND METHODS OF USE
EP1928489A4 (en) Ghrelin Analogs
IL176922A0 (en) Compositions and methods of use of a-type procyanidins
PL1778621T3 (pl) Wytwarzanie jodiksanolu
HK1109332A1 (zh) 藻毒素的經皮給藥
EP1888618A4 (en) GLYCYL-PROLYL-GLUTAMATE ANALOGS
HK1113308A1 (en) Pharmaceutical formulations of gallium salts
EP1711484A4 (en) SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES
EP1786433A4 (en) BETULINOL DERIVATIVES AS ANTI-HIV MEDIUM
EP1850663A4 (en) USE OF MINOXIDILSULFATE AS AN ACTIVE AGAINST CANCER
IL179962A0 (en) Compositions and methods of use of dimer digallates
GB0412584D0 (en) Composition of matter

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161025